THE END IS NEAR

The market is selling off as many Chinese burrito and biotech bombshells apex. The last phase of any bull run is marked by the frothy surge in the offal of the market, the companies who promote their stocks to pump their share prices, so they can do secondaries. When you see those stocks run on their own, without the help of your local denizen of free steak lunches, you know the end is near.

Relax, don’t get too confuddled. The market will only disappoint for a short period of time, at which point you may reenter and celebrate decadence, once again. But before that happens, the tree of prosperity must be nourished with the blood and guts of the uninformed. The easy and new money must be stripped from its holder and tossed into the bonfires of agony.

In other words, go raise some cash.

What about oil? It’s out of favor and no one is thinking about it, with oil sub $100. Perhaps it’s a good time to buy now, before the driving season begins, just prior to the beginning of mind numbing inflation? Of course the latter part of that statement was meant in jest; but truth be told, many a good oil stock has been driven down lately.

I like FANG, CXO and CLR. KOG has been battered too and might be worth a shot. But don’t expect miracles, at least not right away.

I want AFOP to sell off today. While it’s true that China might be slowing for them and their CEO can hardly speak a lick of english, it’s rumored that GOOG is a 40% client of theirs, building out a massive fiber optic network with the aim to control the internet. If they executed correctly, earnings could be much better than expected this quarter.

Other stocks on my long term wish list include: FEYE, YELP and TWTR.

I have a bunch of biotechs on the front burner, such as CLDX, PRAN, RGLS, RMTI and CEMP.

I have about 20% of my assets in cash and would love to see a big pullback; but I’m probably gonna have to buy into the rally, as the catalysts for a pullback lack teeth. The market is running because it is the path of least resistance. Sometimes it’s easier to place your emotions aside and simply go with the flow, until it stops working.

NOTE: Capesize rates rebounded sharply today to over $15,000 per day. However, they are down from $42,000 since XMAS and is certain to have a negative affect on earnings. Just an FYI for those of you holding bulkers into earnings.

Yesterday, some bozo from The Seeking Alpha cesspool posted a series of posts, claiming that VEEV lost Genetech, as a client, to CRM. The result was an immediate gap lower, with the stock sinking 15%–just because some clown from “Suhail Capital” was given a platform to incite fear.

Read the article and notice his frantic writing style, purposely manipulated to cause alarm in readers, hoping they’d sell.

My only question is, why is this ‘gent’ doing such a thing?

As you can plainly see, he is making the Genetech ‘loss” to be a rather big deal. A layman reading this would believe it was VEEV’s largest client. However, the truth is a tad less dire and certainly not wrought with deceit.

According to the companies 8-k, released after the close of trade yesterday, VEEV had this to say about Seeking Alpha’s wild accusations:

Veeva Systems: In 8-K, company says that subscription agreement between VEEV & Genentech expired during 2Q13; Already reflected in previously provided guidance

In an 8-K released after the close, VEEV provides the following information: The subscription agreement between Veeva and Genentech, for use of the Veeva CRM product by Genentech users in the United States, expired during VEEV’s fiscal second quarter, which ended July 31, 2013. The financial impact of the expiration of the Genentech Agreement is reflected in Veeva’s previously provided financial results and guidance. At no time in the last eight completed fiscal quarters was Genentech one of Veeva’s top 20 customers, as measured by revenue in the quarter. VEEV does not believe the circumstances that led to the expiration of the Genentech Agreement are indicative of any trend among its customer base generally and are specific to the relationship between Genentech and Veeva.

In summary, Genetech HASN’T BEEN A TOP 20 CLIENT IN OVER TWO YEARS. I repeat, and this time with a bit more elegance, the stuff allowed to be posted by Seeking Alpha that rocked VEEV for 5 points yesterday, resulting in massive losses for investors, was nothing more or less than a complete and utter fabrication.

The ‘gent’ from Suhail came out with a rebuttal piece this morning. But, quite frankly, I couldn’t read it, as it has the grammatical structure and cadence of being written by an 8 year old.

I’d like to know how much they made by trading ahead of this news and why this modern day bucket shop, called Seeking Alpha, is permitted to continue to cause great harm to investors, without anyone on CNBC or the mass media mentioning their complicity in these crimes against the spartan investor.

I didn’t want to make money today, but made it nonetheless. I was a net buyer today, starting a position in BMRN. I like this one longer term, as a possible takeover candidate for big and lazy pharma. AFOP ran hard today. Every time I mention a new pick, you people run it up. I’ve come to the conclusion that many of you are incapable of thinking for yourselves.

In short, I am expecting RPTP to explode to the upside and soon. I can see myself selling it north of $20, punching faces, laughing merrily, all the way to the bank.

It’s my top pick, bozo.

I added BMRN to the ranks.

Takeover candidate.

Life outside of the market is going swimmingly, might I add. As I type this, I am drinking a cup of scalding hot hot coffee, loaded up with some chocolate whey protein, accompanied by a protein bar. I will soon head over to the gym, where I will partake in squats, and attempt to do irreversible damage to my knees and hips. While some of you go through great lengths to avoid injury, I drive the truck straight towards the nuclear power plant.

I have 4 meaningful positions left: BALT, RPTP, GOGO and ANGI. They’re all up, so this correction isn’t affecting me in the least.

As you know, speculation is still running hot, with many stocks up 10%_ today, for no reason at all. This will soon come to an end, a watery grave type of end, so enjoy it while it lasts.

This is still a healthy market. I’ve been researching AFOP and like what I see, especially the rumor that GOOG is a 40% client, due to its fiber rollout. With the stock off 6 from its high, I like it heading into earnings.

The key phrase there is “heading into earnings,” but not the earnings itself. As a matter of fact, there are very few companies that I want to own during earnings. Based on recent history (e.g. BBY), the market has been unforgiving to any company, with exception to AMZN, that misses. Being at new highs and all, any company that misses will likely catch a 20-30% gravity-hammer to the skull, crushing investors to pieces.

Isn’t it better to simply wait for the turmoil to pass, letting “the others” step on the landmines for you?

I couldn’t be happier than right now, seeing BBY down 30% on the news that it is a horrible store. Now if CONN and HGG could just got to zero already, I could consider myself “a fortunate man.” Bear in mind, I do not stand to profit from this debacle, monetarily. But payment of the soul is far more valuable and I truly enjoy seeing people get their “comeuppance.”

Let’s just throw it out there, shall we? It was a horrible holiday season. No one wants to buy stuff from stores anymore, when AMZN is fixing to deliver wares via mini-helicopters.

In the pre-market, shippers and solar stocks are lifting. The Dry Bulk index is bouncing hard and Jennifer is losing money, yet again, short BALT, post 40% decline in the BDI. It goes to show you, and let this be a lesson to many of you: even if you had tomorrow’s newspaper today, that doesn’t mean you can confidently predict how Wall Street will digest said news.

Earlier today I got to looking at this market, I mean really looking at it, and was disgusted by what I saw. Chinese stock after chinese stock up 50% over the past few weeks. Solar and alternative energy names up double figures in weeks. Biotech hand grenades up triple digits over the past few days. I’ve seen this story before and it always ends with my penis barely escaping the guillotine.

Although I am bullish and believe February will bring us fruits to eat and slobber about our faces with, I am skeptical because it is my nature to be this way. Deep down, I am a very dark, sinister, almost evil, person, parlaying stock ideas for fun because the internet belongs to me. The bold truth is, I am a seller. Do not ask me “what are you selling Fly?” Just know, that I am a seller, of extreme proportions. I cannot find anything to buy. I’d rather be confined to a wheeled chair than be forced to buy NFLX upwards of $300. God save me.

I am in a very dire and dour mood, even though I am hitting new highs, managed my sales at the highs of the session, and made more money today than 95% of people make in a year. Even still, I brood listening to ridiculous music from the 14th century, angry because of reasons unbeknownst to me. Truly.

I don’t even know what that is. But I’m doing it anyway.